Average of confirmed sales; the main valuation baseline.
Lowest active listing; an asking price, not a completed sale.
Reference-price movement; low volume can make it unstable.
More sales reduce the impact of individual transactions.
Sales answer “what is it worth”; listings answer “what does an available copy cost”.
SALES / VALUECompleted eBay sales; useful support, especially for the global market.
Transaction-based price; use it as the valuation baseline.
Transaction-based price; use it as the valuation baseline.
Seller asking prices. They show availability but do not prove demand.
| DATE | SOURCE | Price | Change |
|---|---|---|---|
| 2026-11-07 | Sold | €49.16 | — |
| 2026-11-07 | TCG | $36.52 | — |
| 2026-11-06 | Sold | €49.16 | +0.9% |
| 2026-11-06 | List | €49.99 | -0.0% |
| 2026-11-06 | TCG | $36.52 | -0.5% |
| 2026-11-06 | EB | $49.99 | +10.0% |
| 2026-11-05 | Sold | €48.73 | -0.2% |
| 2026-11-05 | TCG | $36.71 | +0.7% |
| 2026-11-05 | EB | $45.47 | +22.9% |
| 2026-11-04 | Sold | €48.84 | — |
| 2026-11-04 | TCG | $36.46 | -0.1% |
| 2026-11-03 | Sold | €48.84 | -2.3% |
| 2026-11-03 | List | €50.00 | — |
| 2026-11-03 | TCG | $36.50 | -0.3% |
SV: Scarlet & Violet 151 / #167/165/Holofoil
Germany: lowest · United Kingdom: below average · EU average €57.50Choose a region above to inspect its prices and history.
DETAILED PRICES · Price History
| Condition/Grade | Price | LOW | HIGH | 7D CHG | Volume | Spark |
|---|---|---|---|---|---|---|
NMRAW | $36.52 | $36.52 | $36.52 | +0.4% | >5 | |
AggregatedRAW | €49.16 | €25.00 | €165.65 | +0.4% | >5 | |
LPRAW | $32.50 | $32.50 | $32.50 | +0.4% | >5 | |
MPRAW | $32.99 | $32.99 | $32.99 | +0.4% | >5 | |
DMGRAW | $25.37 | $25.37 | $25.37 | +0.4% | >5 | |
HEAVILY PLAYEDRAW | $35.03 | $35.03 | $35.03 | +0.4% | >5 | |
MINTRAW | €49.16 | €25.00 | €165.65 | +0.4% | >5 |
Explore Ivysaur #167/165, Holofoil from SV: Scarlet & Violet 151, with 2531 price records for the US market. Prices above are labeled by source, currency and condition. Asking prices and recorded sales are different measures, not interchangeable valuations.